Loading...
An Advanced Apralog with Increased in-vitro and in-vivo Activity toward Gram-negative Pathogens and Reduced ex-vivo Cochleotoxicity.
We describe the convergent synthesis of a 5-O-β-D-ribofuranosyl-based apramycin derivative (apralog) that displays significantly improved antibacterial activity over the parent apramycin against wild-type ESKAPE pathogens. In addition, the new apralog retains excellent antibacterial activity in the...
Na minha lista:
| Udgivet i: | ChemMedChem |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7855274/ https://ncbi.nlm.nih.gov/pubmed/33007139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.202000726 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|